Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00190814 · ClinicalTrials.gov registry record · Phase 3
Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.
A Phase 3 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 600
- Enrollment target
NCT00190814 is a Phase 3 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 600 participants.
The verdict
NCT00190814, a Phase 3 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 600 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the effectiveness of duloxetine in reducing urinary incontinence(leakage of urine)occurrences in women due to physical stress and leakage that occurs during a strong need(urge) to urinate.
Interventions
- DRUG placebo
- DRUG duloxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2003-09 |
| Est. Completion | 2006-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00190814
The ClinicalTrials.gov registry entry for NCT00190814 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00190814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00190814 about?
NCT00190814 is a clinical study titled "Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.". The purpose of the study is to evaluate the effectiveness of duloxetine in reducing urinary incontinence(leakage of urine)occurrences in women due to physical stress and leakage that occurs during a strong need(urge) to urinate.
What is the current status of trial NCT00190814?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 600 participants. The study started on 2003-09. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00190814?
The interventions under investigation include: placebo (DRUG), duloxetine (DRUG).
Who is sponsoring clinical trial NCT00190814?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.